CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Menopause - Management
What issues should I discuss with a woman before starting HRT?
- The risks and benefits of hormone replacement therapy (HRT).
- The expected duration of treatment:
- Women with premature menopause usually take HRT up to the age of the natural menopause (50 years); at that time, treatment is usually reassessed.
- Topical (vaginal) oestrogen may be required long term. Regular attempts (at least annually) to stop treatment are usually made. Symptoms may recur once treatment has stopped.
- Any possible adverse effects such as breast tenderness or enlargement, nausea, headaches, or bleeding.
© NHS Institute for Innovation and Improvement